Pharmaceuticals & Biotechnology

GlaxoSmithKline Pharmaceuticals Limited

ISIN: INE159A01016 · Data as of Jul 2026
Share: WhatsApp ✕ X
Search another stock:
Active Funds Holding
49
vs Last Month
+1 funds
Total Value
₹2,224.14 Cr
Avg Weight
1.48%
New Entries
6
Exits
5
ℹ️ Index funds and ETFs are excluded. Only actively managed funds reflect genuine fund manager decisions.
Mid Cap Rank #221
₹22.05 K Cr
Avg Mkt Cap · Jan-Jun 2023 (3yr ago)
₹40.59 K Cr
Avg Mkt Cap · Jan-Jun 2026 (latest)
+84.1%
3yr change
SEBI · AMFI Market Cap List
📋 What Changed This Month GlaxoSmithKline Pharmaceuticals Limited is currently held by 49 active mutual funds with total exposure of ₹2,224.14 Cr. This month 6 funds entered and 5 funds exited. quant Healthcare Fund - Growth Option - Direct Plan has the highest allocation at 9.93%. ↓ Scroll down for full fund list and monthly changes.
Trend

How Has Fund Coverage Changed — Last 5 Months?

Month Funds AUM (Cr) AMCs Status
Jul 2026 REFERENCE 49 ₹2,224 49 / 49 ✅ Complete
Jun 2026 48 ₹1,923 49 / 49 ✅ Complete
May 2026 42 ₹1,633 49 / 49 ✅ Complete
Apr 2026 41 ₹1,677 49 / 49 ✅ Complete
Mar 2026 42 ₹1,696 48 / 49

📌 Portfolio changes below are based on Jul 2026 data — the most complete month with 49 AMCs we cover uploaded.

By Category

Which Fund Categories Hold This Stock?

Category Funds Avg Weight Distribution
Equity 20 1.75%
Mid Cap 12 1.05%
ELSS 3 1.31%
Small Cap 3 0.89%
Dividend Yield 2 2.08%
Multi Cap 2 1.81%
Flexi Cap 2 1.63%
Multi Asset 2 0.89%
Balanced Advantage 1 2.42%
Aggressive Hybrid 1 2.13%
Value/Contra 1 0.83%
All Holdings

Which 49 Active Funds Hold GlaxoSmithKline Pharmaceuticals Limited?

Filter:
Fund ↕ Category ↕ Weight ↕ Value ↕ Change ↕
quant Healthcare Fund - Growth Option - Direct Plan
Quant Mutual Fund
Equity 9.93% ₹39.45 Cr +7.89%
Tata India Pharma & Healthcare Fund-Direct Plan-Growth
Tata Mutual Fund
Equity 4.66% ₹71.87 Cr +0.54%
Baroda BNP Paribas Dividend Yield Fund
Baroda BNP Paribas Mutual Fund
Dividend Yield 2.77% ₹16.73 Cr +0.25%
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option
Nippon India Mutual Fund
Equity 2.66% ₹246.64 Cr +0.19%
BAJAJ FINSERV MULTI CAP FUND - DIRECT - GROWTH
Bajaj Finserv Mutual Fund
Multi Cap 2.57% ₹38.77 Cr +0.91%
Bandhan Healthcare Fund - Direct Plan - Growth
Bandhan Mutual Fund
Equity 2.49% ₹7.97 Cr +0.21%
Bajaj Finserv Balanced Advantage Fund-Direct Plan-Growth
Bajaj Finserv Mutual Fund
Balanced Advantage 2.42% ₹30.55 Cr +0.59%
THE WEALTH COMPANY FLEXI CAP FUND
The Wealth Company Mutual Fund
Flexi Cap 2.16% ₹5.35 Cr +0.31%
Tata Aggressive Hybrid Fund -Direct Plan- Growth Option
Tata Mutual Fund
Aggressive Hybrid 2.13% ₹83.65 Cr +0.09%
The Wealth Company Large & Mid Cap Fund
The Wealth Company Mutual Fund
Mid Cap 2.09% ₹2.12 Cr +0.26%
DSP Quant Fund - Direct Plan - Growth
DSP Mutual Fund
Equity 2.05% ₹15.93 Cr +0.13%
BAJAJ FINSERV ELSS TAX SAVER FUND - DIRECT - GROWTH
Bajaj Finserv Mutual Fund
ELSS 2.02% ₹1.80 Cr +0.48%
ICICI Prudential Quant Fund Direct Plan Growth
ICICI Prudential Mutual Fund
Equity 2.01% ₹3.19 Cr +0.05%
Helios Mid Cap Fund - Direct Plan - Growth Option
Helios Mutual Fund
Mid Cap 2.01% ₹39.22 Cr +0.68%
Tata Business Cycle Fund-Direct Plan-Growth
Tata Mutual Fund
Equity 1.69% ₹44.61 Cr +0.15%
Explore More
← Stock Search Top Stocks by MF Conviction Fund Directory AMC AAUM Rankings Market Cap Categories

Data source: Official AMFI monthly portfolio disclosures. Updated every month. Index funds and ETFs excluded. Disclaimer: This is not investment advice. Consult a SEBI-registered advisor before investing.